Tamura K, Manabe T, Imanishi K, Nonaka A, Asano N, Yamaki K, Tobe T
First Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
Hepatogastroenterology. 1992 Feb;39(1):59-61.
The effects of clinically used protease inhibitors (aprotinin, nafamostat mesilate, gabexate mesilate) on the production of oxygen-derived free radicals (O2-, H2O2, .OH) by human polymorphonuclear leukocytes were examined. Nafamostat mesilate and gabexate mesilate markedly and dose-dependently inhibited zymosan-stimulated O2- production by human polymorphonuclear leukocytes. However, aprotinin had a slight scavenging effect on O2- produced by the xanthine-xanthine oxidase system. All the protease inhibitors inhibited H2O2 production, but had no significant scavenging effect on H2O2. Nafamostat mesilate and gabexate mesilate slightly inhibited .OH production. These results indicate that the synthetic protease inhibitors nafamostat mesilate and gabexate mesilate inhibit the production of various activated oxygen radicals by human polymorphonuclear leukocytes, and the differences in their inhibitory effects suggest that each synthetic protease inhibitor is specific for a particular oxygen-derived free radical.
研究了临床使用的蛋白酶抑制剂(抑肽酶、甲磺酸萘莫司他、甲磺酸加贝酯)对人多形核白细胞产生氧衍生自由基(O2-、H2O2、·OH)的影响。甲磺酸萘莫司他和甲磺酸加贝酯显著且呈剂量依赖性地抑制酵母聚糖刺激的人多形核白细胞产生O2-。然而,抑肽酶对黄嘌呤-黄嘌呤氧化酶系统产生的O2-有轻微清除作用。所有蛋白酶抑制剂均抑制H2O2的产生,但对H2O2无明显清除作用。甲磺酸萘莫司他和甲磺酸加贝酯轻微抑制·OH的产生。这些结果表明,合成蛋白酶抑制剂甲磺酸萘莫司他和甲磺酸加贝酯抑制人多形核白细胞产生各种活性氧自由基,它们抑制作用的差异表明每种合成蛋白酶抑制剂对特定的氧衍生自由基具有特异性。